Skip to main content
66°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
63.93
+0.29 (+0.46%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
99
100
Next >
Europe Set To Launch Anti-Subsidy Probe Into Chinese EVs, American Airlines and Spirit Lower Profit Outlook, Manchester United's New Shirt Sponsor: Today's Top Stories
September 13, 2023
Financial Times Europe Set To Launch Anti-Subsidy Probe Into Chinese Electric Vehicles
Via
Benzinga
Moderna, REV Group, Rocket Pharmaceuticals And Other Big Stocks Moving Higher On Wednesday
September 13, 2023
U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Moderna Stock Trading Higher Today?
September 13, 2023
Moderna Inc (NASDAQ: MRNA) announced its intentions to launch up to 15 new products and advance up to 50 mRNA medicines into clinical trials over the next five years.
Via
Benzinga
Check Out What Whales Are Doing With MRNA
September 11, 2023
Via
Benzinga
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
September 11, 2023
Via
ACCESSWIRE
Peering Into Moderna's Recent Short Interest
September 05, 2023
Via
Benzinga
Say Goodbye to Free COVID-19 Shots: CDC Approves Priced Boosters for Omicron Subvariants
September 13, 2023
The Centers for Disease Control and Prevention (CDC) has officially endorsed COVID-19 booster shots for individuals six months and older as we approach the fall season.
Via
Benzinga
Exposures
COVID-19
Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood'
September 13, 2023
Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite.
Via
Investor's Business Daily
Moderna Expands the Field of mRNA Medicine with Positive Clinical Results Across Cancer, Rare Disease, and Infectious Disease
September 13, 2023
Via
ACCESSWIRE
The 3 Most Undervalued Biotech Stocks to Buy in September 2023
September 12, 2023
While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners.
Via
InvestorPlace
DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories
September 12, 2023
Benzinga
Via
Benzinga
Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits
September 11, 2023
The U.S.
Via
Benzinga
Exposures
COVID-19
Product Safety
Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters
September 11, 2023
Novavax says it's working with the FDA to answer final requests as part of the agency's review.
Via
Investor's Business Daily
Exposures
COVID-19
Product Safety
Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market
September 11, 2023
Advancements in healthcare and medicine have helped contribute to the reduction in child mortality rates, plummeting from 185 per 1,000 births a century ago to just 7 per 1,000 births in 2020. However,...
Via
Benzinga
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
September 11, 2023
Via
ACCESSWIRE
3 Meme Stocks That Could Actually Rebound in Q4
September 09, 2023
With meme stocks benefiting from a sector-wide resurgence, these are the compelling wagers you may want to consider.
Via
InvestorPlace
Moderna Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
September 08, 2023
Via
ACCESSWIRE
10 Health Care Stocks With Whale Alerts In Today's Session
September 08, 2023
Via
Benzinga
COVID Vaccine Sales Are Declining. But Here's How They're Still Driving Growth at Moderna.
September 08, 2023
Moderna expects to launch several products over the next few years.
Via
The Motley Fool
Exposures
COVID-19
2 Nasdaq 100 Stocks That Are Surefire Buys in September and 1 to Avoid Like the Plague
September 08, 2023
Two high-growth Nasdaq 100 stocks are phenomenal businesses hiding in plain sight, while another Nasdaq 100 component comes with outsize risk.
Via
The Motley Fool
7 Biotech Stocks to Sell in September Before They Crash & Burn
September 06, 2023
These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues.
Via
InvestorPlace
Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry
September 06, 2023
On Tuesday, UK regulators joined their US and European peers in approving an updated COVID-19 vaccine by Pfizer Inc (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) that targets only the...
Via
Benzinga
Exposures
COVID-19
Moderna to Participate at Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023
Via
ACCESSWIRE
Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant
September 06, 2023
Pirola has about 30 mutations compared with previous omicron versions of the virus.
Via
Investor's Business Daily
Exposures
COVID-19
iPhone 15 May Face Hurdle In China, FTC Could Prosecute Amazon.com Over Antitrust Claims, United Airlines Planes Back In Air: Today's Top Stories
September 06, 2023
Wall Street Journal
Via
Benzinga
Is Moderna's New Vaccine the Answer to the Highly Mutated BA.2.86 COVID-19 Variant?
September 06, 2023
Moderna Inc's (NASDAQ: MRNA) clinical trial data from its research assay confirm that its updated COVID-19 vaccine generates an 8.7-fold increase in neutralizing antibodies in humans against BA.2.86...
Via
Benzinga
Exposures
COVID-19
Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine Generates Strong Immune Response in Humans Against BA.2.86
September 06, 2023
Via
ACCESSWIRE
10 Health Care Stocks With Whale Alerts In Today's Session
September 05, 2023
Via
Benzinga
Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle
September 05, 2023
Last week, The European Commission authorizing Comirnaty, a third version of the updated COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) to be used in EU countries'...
Via
Benzinga
Exposures
COVID-19
A Bull Trap Or More Gas In The Tank? Prepare For The Upcoming Week With MandoTrading!
September 05, 2023
Last week's candle reached into a bearish imbalance, right at the 70% retracement of the current swing range and rejected. Bulls will need a close above that level for another upside push towards the...
Via
Benzinga
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.